abstract |
The present invention relates to pharmaceutical compositions for the treatment of spinal disorders caused by the liberation of TNF-alpha comprising an effective amount of a TNF-alpha inhibitor, as well as a method for treatment of such disorders, and the use of TNF-alpha inhibitors in the preparation of pharmaceutical compositions for such treatment. |